Co formulated with Lopinavir as Kaletra
100-200mg daily in 1 or 2 doses in conjuction with other protease inhibitors
Diahorrea, prolonged QT interval, rash
significant interactions with many other drugs , check drug interactions app
avoid in hepatic impairment
FDA category C
Ritonavir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Signs and symptoms suggestive of pancreatitis (including raised serum lipase) should be evaluated—discontinue if pancreatitis diagnosed